FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809307130> ?p ?o ?g. }

• W2809307130 abstract "Priming insulin pens is recommended to remove air from needles to ensure full dose administration. Little is known regarding how often or how much patients prime during home use or its relation to glucose control. We evaluated patterns of pen priming in patients with type 1 diabetes using NovoPens for insulin administration. Patients were trained on use of pens including how and why to prime for doses. Two sites taught a 2 unit prime, site 3 until insulin seen. Pens were synced to a study phone via a near field communicator and marked as prime or injection. Records were assessed for prime frequency and amount. For this interim analysis, 16,135 pen records from 25 patients were analyzed. The percent of injections with a prime was 80% overall but ranged from 2-99%. Prime amount varied and did not correlate to HbA1C. For patients who primed until insulin seen, 74% of the primes did not necessitate 2 or more units. Prime frequency was defined as low if &lt;25%, variable if 25-75% or consistent if &gt;75%. The frequencies were not evenly distributed; instead patients would prime the majority of the time or infrequently. Percentage of missed prime did not correlate with HbA1C, but seemed to correlate with male gender and younger age. Missed prime of insulin pens is fairly common, but the frequency is variable. Insulin pens which track doses offer important data regarding appropriate use. This information provides insight for education and treatment.GenderHbA1c at enrollmentAge (yrs)Diabetes duration (yrs)No prime (%injections)&lt;2 units primes (%injections)≥2 units primes (%injections)Low primers (&lt;25%)3 men7.9%23990%5%5%Variable (25-75%)3 men6.4%241035%22%43%Consistent (&gt;75%)6 men 13 women7.6%36206%29%65%Overall12 men 13 women7.5% (range 5.3-9.3%)33 (range 17-57)17 (range 2-44)Overall: 20%. Sites teaching 2 units: 19%. Site teaching until insulin seen: 21%.Overall: 25%. Sites teaching 2 units: 7%. Site teaching until insulin seen: 62%.Overall: 55%. Sites teaching 2 units: 74%. Site teaching until insulin seen: 17%. Disclosure G. O'Malley: None. S.J. Ogyaadu: None. D.W. Lam: None. L.M. Norlander: None. J. Robic: None. C.M. Levister: None. S. Anderson: Research Support; Self; Medtronic. Consultant; Self; Senseonics. L. Hsu: None. S.E. Loebner: None. L. Ekhlaspour: None. M.D. Breton: Stock/Shareholder; Self; TypeZero Technologies, Inc.. Speaker's Bureau; Self; Ascensia Diabetes Care. Consultant; Self; Sanofi. Speaker's Bureau; Self; Roche Diabetes Care Health and Digital Solutions. Research Support; Self; Dexcom, Inc., Ascensia Diabetes Care, Senseonics. B.A. Buckingham: Advisory Panel; Self; Novo Nordisk Inc., ConvaTec Inc.. Research Support; Self; Medtronic, Insulet Corporation, Dexcom, Inc., Tandem Diabetes Care, Inc.. Consultant; Self; Tandem Diabetes Care, Inc., Becton, Dickinson and Company. C.J. Levy: Advisory Panel; Self; Medtronic MiniMed, Inc.. Research Support; Self; Lexicon Pharmaceuticals, Inc., Dexcom, Inc.." @default.
• W2809307130 created "2018-06-29" @default.
• W2809307130 creator A5001406800 @default.
• W2809307130 creator A5004275841 @default.
• W2809307130 creator A5034425923 @default.
• W2809307130 creator A5046777934 @default.
• W2809307130 creator A5048738466 @default.
• W2809307130 creator A5049629461 @default.
• W2809307130 creator A5057738176 @default.
• W2809307130 creator A5058517990 @default.
• W2809307130 creator A5063443981 @default.
• W2809307130 creator A5064470413 @default.
• W2809307130 creator A5082669793 @default.
• W2809307130 creator A5089236586 @default.
• W2809307130 creator A5089437051 @default.
• W2809307130 date "2018-07-01" @default.
• W2809307130 modified "2023-09-27" @default.
• W2809307130 title "Trends in Insulin Pen Priming" @default.
• W2809307130 doi "https://doi.org/10.2337/db18-83-lb" @default.
• W2809307130 hasPublicationYear "2018" @default.
• W2809307130 type Work @default.
• W2809307130 sameAs 2809307130 @default.
• W2809307130 citedByCount "0" @default.
• W2809307130 crossrefType "journal-article" @default.
• W2809307130 hasAuthorship W2809307130A5001406800 @default.
• W2809307130 hasAuthorship W2809307130A5004275841 @default.
• W2809307130 hasAuthorship W2809307130A5034425923 @default.
• W2809307130 hasAuthorship W2809307130A5046777934 @default.
• W2809307130 hasAuthorship W2809307130A5048738466 @default.
• W2809307130 hasAuthorship W2809307130A5049629461 @default.
• W2809307130 hasAuthorship W2809307130A5057738176 @default.
• W2809307130 hasAuthorship W2809307130A5058517990 @default.
• W2809307130 hasAuthorship W2809307130A5063443981 @default.
• W2809307130 hasAuthorship W2809307130A5064470413 @default.
• W2809307130 hasAuthorship W2809307130A5082669793 @default.
• W2809307130 hasAuthorship W2809307130A5089236586 @default.
• W2809307130 hasAuthorship W2809307130A5089437051 @default.
• W2809307130 hasConcept C100701293 @default.
• W2809307130 hasConcept C114614502 @default.
• W2809307130 hasConcept C126322002 @default.
• W2809307130 hasConcept C134018914 @default.
• W2809307130 hasConcept C184992742 @default.
• W2809307130 hasConcept C2779306644 @default.
• W2809307130 hasConcept C2781232474 @default.
• W2809307130 hasConcept C33923547 @default.
• W2809307130 hasConcept C555293320 @default.
• W2809307130 hasConcept C59822182 @default.
• W2809307130 hasConcept C71924100 @default.
• W2809307130 hasConcept C81444415 @default.
• W2809307130 hasConcept C86803240 @default.
• W2809307130 hasConceptScore W2809307130C100701293 @default.
• W2809307130 hasConceptScore W2809307130C114614502 @default.
• W2809307130 hasConceptScore W2809307130C126322002 @default.
• W2809307130 hasConceptScore W2809307130C134018914 @default.
• W2809307130 hasConceptScore W2809307130C184992742 @default.
• W2809307130 hasConceptScore W2809307130C2779306644 @default.
• W2809307130 hasConceptScore W2809307130C2781232474 @default.
• W2809307130 hasConceptScore W2809307130C33923547 @default.
• W2809307130 hasConceptScore W2809307130C555293320 @default.
• W2809307130 hasConceptScore W2809307130C59822182 @default.
• W2809307130 hasConceptScore W2809307130C71924100 @default.
• W2809307130 hasConceptScore W2809307130C81444415 @default.
• W2809307130 hasConceptScore W2809307130C86803240 @default.
• W2809307130 hasIssue "Supplement_1" @default.
• W2809307130 hasLocation W28093071301 @default.
• W2809307130 hasOpenAccess W2809307130 @default.
• W2809307130 hasPrimaryLocation W28093071301 @default.
• W2809307130 hasRelatedWork W1587835419 @default.
• W2809307130 hasRelatedWork W1969140965 @default.
• W2809307130 hasRelatedWork W2017030704 @default.
• W2809307130 hasRelatedWork W2084215480 @default.
• W2809307130 hasRelatedWork W2117858992 @default.
• W2809307130 hasRelatedWork W2165831222 @default.
• W2809307130 hasRelatedWork W2185089898 @default.
• W2809307130 hasRelatedWork W2383009242 @default.
• W2809307130 hasRelatedWork W2401868485 @default.
• W2809307130 hasRelatedWork W2412842137 @default.
• W2809307130 hasVolume "67" @default.
• W2809307130 isParatext "false" @default.
• W2809307130 isRetracted "false" @default.
• W2809307130 magId "2809307130" @default.
• W2809307130 workType "article" @default.